Vitamin D and Chronic Illness: Why Deficiency Is Common and What to Do About It

Patients living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID are at an exceptionally high risk for vitamin D deficiency due to the physical realities of navigating their daily lives. The hallmark symptom of ME/CFS is post-exertional malaise (PEM), a severe and debilitating crash in physical, cognitive, and emotional function following even minimal exertion. Because of the unpredictable and severe nature of PEM, many patients are forced to become housebound or bedbound for extended periods just to manage their baseline symptoms and avoid triggering a crash. This forced indoor isolation drastically reduces their exposure to natural ultraviolet B (UVB) sunlight, which is the primary biological catalyst required for the human body to synthesize its own vitamin D in the skin.

As a result of this isolation, a secondary biological effect known as the "deconditioning cycle" takes hold. Research published in the European Journal of Cardiovascular Medicine highlights that the lack of sunlight leads to plummeting vitamin D levels, which in turn directly worsens skeletal muscle weakness and mitochondrial dysfunction. This muscular deconditioning lowers the patient's physical threshold for future crashes, meaning it takes even less exertion to trigger severe PEM. It becomes a vicious, self-perpetuating cycle where the illness prevents sunlight exposure, and the resulting nutritional deficiency amplifies the physical limitations of the illness.

Beyond physical deconditioning, the biological demand for vitamin D skyrockets during and immediately after a severe viral infection. When the body encounters a novel pathogen like SARS-CoV-2, the immune system rapidly consumes available circulating vitamin D to produce essential antimicrobial peptides and to regulate the aggressive inflammatory response. In conditions like Long COVID, the immune system often fails to return to a normal resting state, leading to a phenomenon known as chronic systemic inflammation and persistent immune dysregulation. You can learn more about this complex process in our guide on Autoimmunity and Immune Dysregulation in Long COVID.

This ongoing, invisible immunological battle continuously depletes the body's stored vitamin D reserves, leaving very little left over for essential neurological maintenance and musculoskeletal repair. According to studies in the Journal of Clinical Endocrinology & Metabolism, this viral depletion prevents the immune system from properly "cooling down," effectively trapping the patient in a prolonged state of hyper-inflammation. Without adequate vitamin D to act as an immunological dimmer switch, the body continues to produce pro-inflammatory cytokines that drive the severe brain fog and profound exhaustion reported by so many Long COVID survivors.

For individuals living with fibromyalgia, the nutritional challenge is compounded by central nervous system sensitization and widespread, unyielding musculoskeletal pain. Severe vitamin D deficiency can directly cause a physiological condition known as mild osteomalacia, which is the physical softening of the bone tissue. This condition presents as generalized, deep bone and muscle aching that perfectly mimics, masks, or severely aggravates the baseline pain already experienced in fibromyalgia. When a patient is deficient, their skeletal muscles also develop a hyperinnervation of pain receptors, making them exquisitely sensitive to even light mechanical pressure.

Furthermore, the chronic pain associated with fibromyalgia naturally leads to reduced physical activity, disrupted sleep architecture, and higher rates of indoor isolation. This creates a confounding clinical loop where the severe pain prevents outdoor sunlight exposure, and the resulting vitamin D deficiency neurologically amplifies the pain signals in the brain and spinal cord. Recent meta-analyses suggest that addressing this specific nutritional gap is absolutely critical, as replenishing vitamin D can remove a significant layer of physical suffering from the patient's overall symptom burden, allowing other pain management therapies to work more effectively.

Despite its name, vitamin D is not technically a vitamin; it is a highly potent, systemic steroid prohormone that interacts with nearly every tissue in the human body. Its most critical role in the context of chronic illness is its function as a master immunomodulator. In the innate immune system, vitamin D stimulates the production of powerful antimicrobial peptides, such as cathelicidin and defensins, which act as the body's first line of defense against invading pathogens. In the adaptive immune system, it plays a crucial role in preventing autoimmune responses by inhibiting the overactivation of Th1 and Th17 cells, which are responsible for driving destructive "cytokine storms."

Simultaneously, research published in PMC demonstrates that vitamin D promotes the development of regulatory T-cells (Tregs), which are specialized cells that teach the immune system tolerance and tell it when to stop attacking. In the brain, vitamin D acts as a neuroprotective agent that maintains the physical integrity of the blood-brain barrier and aids in monoamine neurotransmission. When levels are optimized, it helps reduce the severe neuroinflammation and microglial activation that are believed to be the primary drivers of the cognitive dysfunction, or "brain fog," seen in both Long COVID and ME/CFS.

It is a common clinical misconception that taking high doses of vitamin D alone is enough to correct a deficiency. In reality, you can take massive doses of vitamin D, but without adequate magnesium, it will remain stored and biologically inactive in your body. Vitamin D must be metabolized first in the liver and then in the kidneys into its biologically active form, known as 1,25-dihydroxyvitamin D. According to a comprehensive review in the Journal of the American Osteopathic Association, magnesium is an absolute, non-negotiable cofactor for all of the enzymatic reactions that metabolize and activate vitamin D.

If you begin taking high doses of vitamin D without ensuring sufficient magnesium intake, your body will rapidly drain its existing magnesium stores to process the new vitamin D. This depletion can trigger a host of new symptoms, including muscle cramps, heart palpitations, and increased anxiety—symptoms that many dysautonomia and POTS patients already struggle with daily. To understand how to safely incorporate this crucial mineral, explore our detailed guide: Can Magnesium Glycinate Support Energy and Calm the Nervous System in Long COVID and POTS?.

While vitamin D is responsible for increasing the intestinal absorption of calcium into the bloodstream, it does not have the ability to control where that calcium ultimately ends up depositing in the body. This is where vitamin K2 (specifically the menaquinone-7 or MK-7 form) becomes an absolutely critical companion nutrient. Vitamin K2 acts as a biological "traffic cop" for calcium by activating two highly specific proteins: osteocalcin and matrix Gla-protein (MGP). Osteocalcin is responsible for taking the calcium from the blood and binding it directly into the bone matrix, thereby improving bone mineral density and skeletal strength.

Conversely, matrix Gla-protein (MGP) is a powerful inhibitor of soft tissue calcification. Clinical trials published in Circulation have shown that activated MGP actively prevents circulating calcium from depositing in arterial walls, kidney tissues, and heart valves. When patients take high doses of vitamin D without vitamin K2, they run the risk of hypercalcemia leading to arterial stiffness and cardiovascular complications over time. Therefore, the synergistic combination of D3 and K2 is widely considered a mandatory best practice for long-term cardiovascular and skeletal safety.

The clinical data connecting vitamin D deficiency to the severity and persistence of Long COVID symptoms is becoming increasingly robust. Observational studies consistently show that a vast majority of patients suffering from post-acute sequelae of SARS-CoV-2 have significantly low serum 25-hydroxyvitamin D levels. A 2024 study published in MDPI examining 97 Long COVID patients infected during the Omicron wave found that a staggering 68% were clinically diagnosed with severe vitamin D deficiency. Furthermore, these deficient patients reported significantly higher severity scores for persistent fatigue, shortness of breath, and musculoskeletal pain compared to those with sufficient levels.

Another prospective cohort study of 350 post-hospitalized COVID-19 patients measured vitamin D levels at discharge and followed up six months later. The researchers found that 68.1% of the vitamin D-deficient patients had developed Long COVID, compared to only 42.9% of those with sufficient levels. After adjusting for confounding factors like age and initial disease severity, the study concluded that vitamin D deficiency was independently associated with a 2.35-fold increased risk of developing Long COVID. Reviews in Biomolecules suggest this is largely due to unmitigated mitochondrial reactive oxygen species (ROS) and persistent immune activation that vitamin D normally suppresses.

Historically, the medical evidence regarding vitamin D supplementation in ME/CFS was mixed, largely because earlier studies did not control for baseline deficiencies or utilize comprehensive metabolic protocols. However, recent targeted clinical trials have yielded highly promising, validating results for the patient community. A 2025 cross-sectional study of 100 adult patients diagnosed with ME/CFS found that 68% were clinically deficient and 22% had insufficient levels, leaving only 10% of the patient population with adequate vitamin D status. The researchers noted a statistically significant negative correlation between blood vitamin D levels and the severity of the patients' daily fatigue.

Even more compelling is a groundbreaking open-label randomized controlled trial published in early 2026, which investigated 91 patients who developed ME/CFS following a viral infection. The intervention group received a comprehensive protocol of active vitamin D supplementation, dietary counseling, and paced sunlight exposure for 12 weeks. Strikingly, 16 participants in the intervention group achieved such a significant reduction in their symptom count that they no longer met the diagnostic criteria for ME/CFS, compared to only 1 participant in the control group. This strongly supports the necessity of aggressive, monitored nutritional correction in post-viral fatigue syndromes.

In the realm of fibromyalgia research, vitamin D is increasingly recognized as a highly valuable, low-cost adjunctive therapy for managing chronic widespread pain. Because the symptoms of hypovitaminosis D (severe muscle weakness, bone aching, and profound fatigue) perfectly mirror the diagnostic criteria of fibromyalgia, clinical guidelines now strongly suggest that all fibromyalgia patients undergo routine screening for 25-hydroxyvitamin D deficiency. Recent systematic reviews and meta-analyses assessing the impact of vitamin D on fibromyalgia-related pain have found highly significant clinical improvements across multiple patient cohorts.

These meta-analyses demonstrated that targeted supplementation reduced overall pain levels with a Standardized Mean Difference (SMD) of -0.85 on the Visual Analog Scale. Furthermore, patients reported significantly improved overall quality of life and reduced depressive symptoms on the Fibromyalgia Impact Questionnaire (FIQ). While researchers are careful to note that vitamin D is not a standalone "cure" for the central nervous system sensitization that causes fibromyalgia, replenishing deficient levels effectively removes the compounding layer of musculoskeletal pain, allowing primary therapies and pacing strategies to work much more effectively.

When navigating the world of vitamin D supplementation, understanding the difference between the available forms is critical for achieving therapeutic success. Vitamin D is primarily available in two forms: Vitamin D2 (ergocalciferol) and Vitamin D3 (cholecalciferol). Vitamin D2 is derived primarily from plant sources, fortified foods, and certain older prescription supplements. In contrast, Vitamin D3 is the exact endogenous form produced naturally in human skin upon sunlight exposure, and it is typically sourced from lanolin (sheep's wool) or specialized lichen for over-the-counter supplements.

Clinical evidence overwhelmingly suggests that Vitamin D3 is vastly superior to D2 for raising and maintaining blood serum levels. A landmark clinical study published in the Journal of Clinical Endocrinology & Metabolism compared the effects of high-dose D2 versus D3 regimens. The researchers found that D3 increased total 25-OH vitamin D levels by an average of +27.6 ng/mL, whereas the exact same dose of D2 only raised levels by +12.2 ng/mL. Because D3 is more bioavailable and has a longer half-life in the body, it is the strongly preferred form for managing chronic illness. For a deeper dive into high-dose D3 strategies, read: Can Vitamin D3 50,000 IU Support Energy and Immune Function in Long COVID and ME/CFS?.

Determining the correct dosage of vitamin D requires a personalized approach based on baseline blood work, as maintenance dosing and therapeutic correction dosing are vastly different. The standard recommended daily allowance for healthy adults is typically between 600 to 800 IU, which is generally only sufficient to prevent severe bone diseases like rickets. However, for patients with complex chronic illnesses seeking to correct an active deficiency, functional medicine practitioners often utilize therapeutic doses ranging from 5,000 to 10,000 IU daily, or even 50,000 IU weekly, until optimal serum levels are achieved.

The safety profile of these higher therapeutic doses is well-documented in the medical literature. A massive 7-year study by McCullough et al. found that daily doses ranging from 5,000 to 50,000 IU safely increased blood levels without causing elevated parathyroid hormone (PTH) or dangerous hypercalcemia. Once a patient's levels reach the optimal functional range (typically between 40 to 60 ng/mL), providers will usually transition them to a lower daily maintenance dose. Alongside vitamin D, many patients also explore other energy-supporting compounds; you can learn more in our guide: Can Adaptogens Support Energy Levels for Long COVID and ME/CFS Patients?.

In recent years, specialized high-dose regimens, such as the Coimbra Protocol, have gained attention in the autoimmune and chronic illness communities. This protocol utilizes ultra-high doses of vitamin D—sometimes ranging from 40,000 to 300,000 IU per day—based on the theory of "acquired vitamin D resistance." A 2022 study published in Nutrients reported on the safety of this protocol in 319 autoimmune patients. While the treatment showed promise in halting disease progression, it is absolutely critical to understand that these extreme doses are only safe when accompanied by mandatory, strict dietary calcium restrictions (zero dairy) and massive daily fluid intake (2.5 liters) to protect the kidneys.

Despite the fears surrounding vitamin D toxicity (hypervitaminosis D), true clinical toxicity is exceedingly rare and usually only occurs with chronic, unmonitored daily doses exceeding 40,000 IU over many months. A 16-year retrospective study analyzing over 127,000 vitamin D measurements found that only 0.12% of patients had levels exceeding the toxicity threshold of 120 ng/mL, and only four individuals exhibited actual clinical symptoms of hypercalcemia. While the safety margin is incredibly wide, high-dose supplementation should never be attempted without rigorous laboratory monitoring and direct supervision from a qualified healthcare provider.

When patients are diagnosed with a vitamin D deficiency, their first instinct is often to try and correct the imbalance through dietary changes alone. Unfortunately, obtaining sufficient, therapeutic amounts of vitamin D from a standard diet is notoriously difficult, if not biologically impossible for those with severe deficiencies. Very few foods in the human diet naturally contain vitamin D in high enough concentrations to move the needle on a blood test. In fact, dietary intake alone averages around a mere 196 IU per day in unsupplemented adult populations, which falls drastically short of the thousands of units required to correct a clinical deficiency.

For patients battling the severe fatigue of ME/CFS or the cognitive impairment of Long COVID, overhauling a diet to meticulously track trace amounts of vitamin D can also cost precious energy they simply do not have. While a nutrient-dense, anti-inflammatory diet is a foundational pillar of managing chronic illness, it must be viewed as a supportive measure rather than a standalone cure for hypovitaminosis D. To explore other dietary strategies that support inflammation management, consider reading our guide: Can Curcumin Support Brain Fog and Inflammation in Long COVID and ME/CFS?.

If you are looking to maximize your natural dietary intake of vitamin D, marine sources are unequivocally the most potent option available. The absolute best natural sources are the flesh of wild-caught, fatty fish, including sockeye salmon, mackerel, sardines, herring, anchovies, and trout. A single 3.5-ounce serving of cooked wild salmon can provide anywhere from 400 to 900 IU of vitamin D3, depending on the quality and source of the fish. Fish liver oils, particularly traditional cod liver oil, are also incredibly dense in naturally occurring vitamin D and have been used for generations to prevent rickets and support immune health.

Incorporating these marine sources into your weekly meal planning offers dual benefits for chronic illness management. Not only do they provide a highly bioavailable form of vitamin D3, but they also deliver massive amounts of Omega-3 fatty acids (EPA and DHA). Research extensively documents that Omega-3 fatty acids have potent, systemic anti-inflammatory properties that help calm overactive microglial cells in the brain and reduce the widespread joint and muscle pain associated with fibromyalgia and post-viral syndromes. Aiming for two to three servings of sustainably sourced oily fish per week is a highly recommended dietary baseline.

For individuals who follow a plant-based diet or do not consume seafood, the dietary options for naturally occurring vitamin D are severely limited. The most notable plant-based exception is mushrooms, but with a significant caveat: mushrooms only contain vitamin D if they have been deliberately exposed to ultraviolet (UV) light during their growing process. Similar to human skin, mushrooms can synthesize vitamin D (specifically the D2 form) when exposed to UV radiation. When shopping, look specifically for UV-exposed chanterelles, button, or cremini mushrooms, which are often clearly labeled as "high in vitamin D" in the produce section.

Because natural food sources are so scarce, many countries rely heavily on public health fortification programs to prevent widespread population deficiency. Top fortified sources include cow's milk, plant-based milk alternatives (like almond, soy, and oat milk), breakfast cereals, margarines, and certain brands of orange juice. While these fortified foods can help maintain baseline levels in healthy individuals, they typically only offer about 100 to 150 IU per serving. Therefore, while they are helpful additions to a balanced diet, they are rarely sufficient on their own to reverse the severe deficiencies commonly seen in Long COVID and ME/CFS patients.

The first and most crucial step in optimizing your vitamin D status is obtaining an accurate baseline measurement of your current blood levels. The standard, gold-standard diagnostic tool used by medical professionals is the 25-Hydroxy Vitamin D test (often written on lab requisitions as 25-OH Vitamin D). According to clinical testing guidelines from Quest Diagnostics, this specific test measures the total amount of 25-hydroxyvitamin D circulating in your bloodstream, accurately capturing both the D2 and D3 forms to provide a comprehensive picture of your nutritional status. It is important to specifically request this test, as other markers like 1,25-dihydroxyvitamin D can fluctuate wildly and do not accurately reflect your body's true tissue stores.

Understanding your lab results is equally important, as the "normal" reference range provided by standard laboratories often differs significantly from the "optimal" range targeted by functional medicine practitioners. Standard labs typically define deficiency as anything below 20 ng/mL, and insufficiency as 20–29 ng/mL. However, for patients actively managing complex chronic illnesses, neuroinflammation, and severe fatigue, many specialists aim for a much higher, optimal therapeutic target of 40 to 60 ng/mL. Knowing your exact starting number allows your healthcare provider to calculate a precise, personalized dosing strategy rather than guessing with over-the-counter amounts.

Because vitamin D is a fat-soluble prohormone, the timing and context of how you take your supplement dramatically impacts how much of it actually enters your bloodstream. If you take a vitamin D capsule on an empty stomach or with a simple glass of water, a significant percentage of the active ingredient will pass through your digestive tract unabsorbed. To maximize intestinal absorption, clinical guidelines strongly recommend taking your vitamin D supplement alongside the largest meal of your day, specifically one that contains a healthy source of dietary fat, such as avocados, olive oil, nuts, or eggs.

Furthermore, the absorption and utilization of vitamin D are highly dependent on the synergistic cofactors we discussed earlier. Implementing a comprehensive supplementation strategy means not just taking D3 in isolation, but pairing it intelligently with magnesium to ensure proper hepatic and renal activation, and vitamin K2 to ensure the resulting calcium is safely routed into the skeletal system rather than the cardiovascular system. Many high-quality, clinical-grade supplements now combine D3 and K2 into a single liquid or capsule formulation to simplify this process for patients dealing with the cognitive fatigue of chronic illness.

While vitamin D is generally very safe, it is biologically active and can interact with several common prescription medications. For example, corticosteroid medications (like prednisone), which are frequently prescribed to manage severe inflammation in autoimmune conditions, can drastically reduce calcium absorption and impair vitamin D metabolism. Additionally, certain weight-loss drugs (like orlistat) and cholesterol-lowering statins can interfere with the intestinal absorption of all fat-soluble vitamins, meaning you may require a higher dose of vitamin D to achieve the same blood levels as someone not taking those medications.

Because of these complex pharmacological interactions, and the specific risks associated with hypercalcemia, it is a HARD REQUIREMENT to consult directly with your primary care physician, rheumatologist, or functional medicine provider before starting, stopping, or significantly altering any high-dose vitamin D regimen. Your provider can help you navigate potential drug-nutrient interactions, monitor your serum calcium and parathyroid hormone levels, and ensure that your supplementation strategy is safely integrated into your broader chronic illness management plan.

Living with Long COVID, ME/CFS, or fibromyalgia often feels like navigating a maze in the dark. While optimizing your vitamin D levels is not a magical cure that will instantly erase complex chronic illness, it is a foundational, scientifically validated step toward rebuilding your body's biological baseline. By correcting a severe deficiency, you provide your immune system with the necessary tools to regulate inflammation, support your mitochondria in producing vital cellular energy, and protect your neurological pathways from the compounding effects of chronic pain. It is a practical, accessible intervention that can significantly improve your daily quality of life and make your other pacing and management strategies more effective.

At RTHM, we understand the profound frustration of dealing with invisible, debilitating symptoms and the importance of utilizing high-quality, evidence-based interventions. We are committed to providing validating, clinically grounded resources to help you manage your complex health journey. If you and your healthcare provider have determined that targeted supplementation is the right next step for your recovery protocol, we invite you to explore our curated selection of clinical-grade formulas designed specifically for the unique needs of chronic illness patients.